Synonyms: CMX-001 | CMX001 | HDP-CDV | hexadecyloxypropyl cidofovir | Tembexa®
brincidofovir is an approved drug (FDA (2021))
Compound class:
Synthetic organic
Comment: Brincidofovir is an orally bioavailable, lipid-conjugated (to enhance cellular penetration) ester prodrug of the acyclic nucleoside monophosphate antiviral cidofovir. The active metabolite is cidofovir diphosphate, which disrupts viral DNA polymerase activity and viral DNA replication. Brincidofovir has been investigated for infections caused by several virus families, including cytomegalovirus (CMV), BK virus (BKV), adenoviruses (AdV) [1], HPV [4], and Epstein-Barr virus (EBV), as well as for smallpox (Variola) infections.
A molecular docking study has indicated that brincidofovir interacts with both host ACE2 and SARS-CoV-2 3C-like (main) protease [2]. Further studies would be required to validate brincidofovir as a potential therapy for SARS-CoV-2 infection. |
|
References |
1. Chan SY, Prockop SE, Boulad F, Papanicolaou GA, Lee YJ. (2021)
Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection. Infect Chemother, 53 (3): 572-577. [PMID:32869551] |
2. Hussien MA, Abdelaziz AEM. (2020)
Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease. Netw Model Anal Health Inform Bioinform, 9 (1): 56. [PMID:32834922] |
3. Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM, Morgan CN, Ostergaard SD, Hughes CM, Nakazawa Y, Kling C et al.. (2021)
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model. mSphere, 6 (1). DOI: 10.1128/mSphere.00927-20 [PMID:33536322] |
4. Richardson BE. (2021)
Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study. Ann Otol Rhinol Laryngol, 130 (12): 1383-1391. [PMID:33834883] |
5. Tichý T, Andrei G, Dračínský M, Holý A, Balzarini J, Snoeck R, Krečmerová M. (2011)
New prodrugs of Adefovir and Cidofovir. Bioorg Med Chem, 19 (11): 3527-39. [PMID:21565516] |